do glp 1 agonists have cardiovascular benefit GLP-1 in Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies do glp 1 agonists have
Description
Patient characteristics affecting the tumor risk of GLP-1RAs Age and gender Meta-analyses have demonstrated that GLP-1RAs reduce the risk of prostate cancer, particularly in older male populations [115]

Methods We systematically searched PubMed, Embase and Cochrane for randomized controlled trials (RCTs) comparing GLP-1 receptor agonists versus

This is where the story gets interesting.

Rosenbaum SB, Gupta V, Patel, P, Palacios JL

silymarin in 5-week-old male Wistar rats, starting at the third week of NAFLD induction and continued for another 3 weeks

Mega C, Teixeira de Lemos E, Vala H, et al
